Physician profile
Craig Shouse
NPI 1760801195
$2,047.38
in general payments reported to CMS, 2019-2025
15 companies · $404 in 2025
The $404 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $595 · 2020: $271 · 2021: $166 · 2022: $180 · 2023: $75.19 · 2024: $356 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $506.08 | 2019-2022 | |
| Kerecis Limited | $417.57 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Tactile Systems Technology INC | $347.65 | 2019-2021 | |
| Mimedx Group, INC. | $176.92 | 2025 | |
| Stryker Corporation | $115.91 | 2019-2025 | Flexband, Swanson |
| Paratek Pharmaceuticals, INC. | $115.50 | 2024-2025 | Nuzyra |
| Kci USA, INC. | $82.66 | 2019 | |
| Melinta Therapeutics, LLC | $52.48 | 2019 | |
| Zimmer Biomet Holdings, INC. | $48.75 | 2020 | |
| Organogenesis INC. | $44.25 | 2020-2021 | |
| Integra Lifesciences Corporation | $36.15 | 2019-2021 | |
| Treace Medical Concepts, INC. | $35.25 | 2022-2024 | |
| Globus Medical, INC. | $32.71 | 2025 | Senza |
| Pfizer INC. | $24.29 | 2019 | |
| Baudax Bio INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Shouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.